Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J V Watson

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Journal of Clinical Pathology|October 1, 1990
Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumoursP A van Dam, J V Watson, D G Lowe, et al.
Cancer|July 1, 1991
Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2P A van Dam, D G Lowe, J V Watson, et al.
Histochemistry|January 1, 1986
The application of flow cytophotometry in measurements of cell adhesionK Ostrowski, J V Watson, P J Barnard, et al.
British Journal of Cancer|November 1, 1994
Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cellsP J Smith, S Souès, T Gottlieb, et al.
Gynecologic Oncology|September 1, 1991
Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tractP A van Dam, D G Lowe, J V Watson, et al.
Journal of Cell Science|February 22, 2000
Mammalian S-phase checkpoint integrity is dependent on transformation status and purine deoxyribonucleosidesC S Downes, C Z Bachrati, S J Devlin, et al.
Anticancer Research|July 1, 1983
Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum)D H Jones, N M Bleehen, R M Grant, et al.
Journal of Clinical Pathology|October 1, 1994
Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinomaP A van Dam, I B Vergote, D G Lowe, et al.
The EMBO Journal|August 1, 1985
Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycleP H Rabbitts, J V Watson, A Lamond, et al.
British Journal of Cancer|October 1, 1985
Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma)H Baillie-Johnson, P R Twentyman, N E Fox, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Journal of Clinical Pathology|October 1, 1990
Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumoursP A van Dam, J V Watson, D G Lowe, et al.
Cancer|July 1, 1991
Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2P A van Dam, D G Lowe, J V Watson, et al.
Histochemistry|January 1, 1986
The application of flow cytophotometry in measurements of cell adhesionK Ostrowski, J V Watson, P J Barnard, et al.
British Journal of Cancer|November 1, 1994
Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cellsP J Smith, S Souès, T Gottlieb, et al.
Gynecologic Oncology|September 1, 1991
Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tractP A van Dam, D G Lowe, J V Watson, et al.
Journal of Cell Science|February 22, 2000
Mammalian S-phase checkpoint integrity is dependent on transformation status and purine deoxyribonucleosidesC S Downes, C Z Bachrati, S J Devlin, et al.
Anticancer Research|July 1, 1983
Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum)D H Jones, N M Bleehen, R M Grant, et al.
Journal of Clinical Pathology|October 1, 1994
Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinomaP A van Dam, I B Vergote, D G Lowe, et al.
The EMBO Journal|August 1, 1985
Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycleP H Rabbitts, J V Watson, A Lamond, et al.
British Journal of Cancer|October 1, 1985
Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma)H Baillie-Johnson, P R Twentyman, N E Fox, et al.
Pageof 12